Source: Annual Congress 2013 –COPD diagnosis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Kobylyanskiy, E. Soyustova, T. Turusina, G. Babadzhanova, E. Musalevskay, Y. Suntsov (Moscow, Russian Federation). Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients. Eur Respir J 2013; 42: Suppl. 57, 1543

Member's Comments

No comment yet.

Related content which might interest you: To improvement of diagnostics of the diabetes mellitus 2 type at patients with chronic obstructive pathology of lungs Source: International Congress 2014 – COPD: points to ponder Year: 2014 Impact of hyperglycaemia and comorbid diabetes mellitus on short and long-term outcome after COPD exacerbation Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort Source: International Congress 2014 – Clinical presentations Year: 2014 Characteristics of essential hypertension in COPD patients Source: International Congress 2014 – COPD: points to ponder Year: 2014 The evaluation of systemic inflammation in COPD patients comorbided with cardiovascular diseases or diabetes mellitus Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Anemia in patients with chronic obstructive pulmonary disease - Association with comorbidities Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Cardiovascular diseases (CVD), arterial hypertension (AH) and diabetes mellitus (DM) in a cohort of 609 COPD patients: Associations with the new GOLD classification 2011 Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 Comorbidities in patients with COPD and their impact on COPD course Source: International Congress 2014 – Prevalence of COPD and mortality from COPD Year: 2014 Impact of diabetes mellitus on treatment outcomes of patients with active tuberculosis in an endemic area Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 Prevalence of COPD in vascular diseases Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015 Prevalence of chronic kidney disease (CKD) in the UK COPD population Source: International Congress 2014 – COPD exacerbations Year: 2014 Obesity and impairments in chronic obstruction pulmonary disease (COPD) Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus Source: International Congress 2018 – COPD and extrapulmonary comorbidities Year: 2018 Secondary prevention of osteoporosis (OP) in chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Best abstracts in COPD management Year: 2015 Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 C-reactive protein at discharge, diabetes mellitus and ≥1 prior hospitalization predict early readmission in patients with acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Do co-morbidities in patients with chronic obstructive pulmonary disease affect outcomes? Source: International Congress 2014 – The assessment of comorbidities Year: 2014 Impact of diabetes in patients with COPD Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020